Antisense Deoxyoligonucleotides Inhibit Activities of Matrix Metalloproteinase-2 in Human Fibrosarcoma HT1080 Cells

Abstract

Insights

Antisense oligodeoxynucleotides (ODNs) targeting matrix metalloproteinase-2 (MMP-2) effectively inhibited tumor cell invasion. Antisense-6 demonstrated significant dose-dependent reduction in MMP-2 activity, mRNA, protein, and cell invasion, suggesting therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Matrix metalloproteinase-2 (MMP-2), a 72 kDa type IV collagenase, is crucial for tumor cell migration and growth.
  • MMP-2 facilitates tumor invasion by degrading the basement membrane.
  • MMP-2 activation correlates with the invasiveness of various cancers.

Purpose of the Study:

  • To investigate sequence-specific phosphorothioated oligodeoxynucleotides (ODNs) for inhibiting MMP-2 translation.
  • To evaluate the impact of these ODNs on tumor cell invasiveness.

Main Methods:

  • Eight types of antisense ODNs were designed and transfected into HT1080 fibrosarcoma cells.
  • MMP expression was assessed using gelatin zymography, Western blot, and Northern blot.
  • In vitro invasion was evaluated using matrigel assays.

Main Results:

  • Antisense-5, antisense-6, and antisense-7 significantly reduced MMP-2 activity in HT1080 cell culture supernatant.
  • Antisense-6 demonstrated a dose-dependent inhibition of MMP-2 mRNA and protein expression.
  • Antisense-6 treatment resulted in a dose-dependent reduction of in vitro tumor cell invasion.

Conclusions:

  • Antisense-6 shows promise as a therapeutic agent for inhibiting tumor invasion and metastasis.
  • Targeting MMP-2 translation with specific ODNs is a viable strategy for cancer therapy.